News

Rivers State records highest number of COVID-19 cases, one death recorded across states, FCT

Join Our Telegram Channel  

Rivers state records 164 cases of COVID-19 infection, the Federal Capital Territory and 12 other states reported 296 new cases of COVID-19 on Monday, according to figures released on Tuesday by the Nigeria Centre for Disease Control.

The NCDC disclosed on its official website on Tuesday that one COVID-19 related death was recorded.

According to the agency, the 460 new cases were recorded from the Rivers, FCT, and 12 other states.

Rivers reported the highest number of new infections with 164 cases, Lagos State – 139, Edo State – 61, Federal Capital Territory – 37, Bayelsa State – 20, Oyo State – 14, Plateau State – 7, Ogun State – 6, Anambra State – 4, Benue State – 4, Enugu State – 2 while Cross River State and Kaduna State reported a single case each.

The health agency said the 460 COVID-19 infections have brought the number of confirmed COVID-19 cases in the country to 191,805. However, 178,492 COVID-19 patients have recovered and have been discharged in the country since the first COVID-19 case was reported, the agency said.

With one COVID-19 related death reported, the death toll from the virus is now 2,455, NCDC said.

Recall that the Lagos State Government had on Sunday said it will resume the administration of second doses of the AstraZeneca COVID vaccine, on Monday 30th August 2021, to persons who have received the first dose of the vaccine during the first phase of the vaccination exercise in the state.

Following this announcement, residents of Ifako-Ijaiye and Agege, Lagos came out in large numbers on Monday for the COVID-19 vaccination exercise at the Ifako-Ijaiye General Hospital, which is one of the designated vaccination sites in Lagos and residents of the area came out en mass to receive the Oxford/Astrazeneca and the Moderna COVID-19 vaccines respectively.

Leave a Comment

Do you find Netxclusive useful? Click here to give us five stars rating!

Related Posts

 


No one has commented yet. Be the first!
Leave a Reply